Development of a lyophilized formulation for (R,R)-formoterol (L)-tartrate

Drug Development and Industrial Pharmacy

Volumn 27, Issue 1, 2001, Pages 89-96

  Kirsch, L ^a   Zhang, S ^a   Muangsiri, W ^a   Redmon, M ^a   Luner, P ^a   Wurster, D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Formoterol; Lactose formulation; Lyophilization; Solid state instability

Indexed keywords

ACETIC ACID; FORMOTEROL; LACTOSE; MANNITOL; TARTARIC ACID;

ARTICLE; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; FREEZE DRYING; HUMIDITY; SOLID STATE; TEMPERATURE; THERMOSTABILITY; TIME; X RAY POWDER DIFFRACTION;

BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; ETHANOLAMINES; EXCIPIENTS; HUMIDITY; TARTRATES; TEMPERATURE;

EID: 0035120414     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100000132     Document Type: Article

References (6)

1. Pre-clinical and metabolic profiles of (R.R) eformoterol
2. Effects of eformoterol on antigen-induced contractions and neurokinin a release in guinea pig airways
3. Effects of eformoterol enantiomers on in vitro bronchial reactivity